55 related articles for article (PubMed ID: 27784351)
1. [Establishment of Mouse Model with Humanized Chronic Myeloid Leukemia].
Xu YJ; Jia WH; Liu CC; Chen WR; Li DP; Huang YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1329-1333. PubMed ID: 27784351
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary establishment of transplanted human chronic myeloid leukemia model in nude mice].
Li XM; Ding X; Zhang LZ; Cen JN; Chen ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1378-82. PubMed ID: 22169287
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a transplantable human myeloid BALB/c nude mouse model.
Wei YM; Lin JH; Xia R; Lan JC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):596-600. PubMed ID: 16129041
[TBL] [Abstract][Full Text] [Related]
4. [Establishment and Identification of SCL-tTA/BCR-ABL Transgenic Mouse Model with Chronic Myeloid Leukemia].
Lin Y; Fu W; Liang YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):24-29. PubMed ID: 28245370
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
6. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
7. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
8. CBL-B is required for leukemogenesis mediated by BCR-ABL through negative regulation of bone marrow homing.
Badger-Brown KM; Gillis LC; Bailey ML; Penninger JM; Barber DL
Leukemia; 2013 Apr; 27(5):1146-54. PubMed ID: 23160449
[TBL] [Abstract][Full Text] [Related]
9. [Establishment of a nude mouse model of human monocytic leukemia with multi-organ infiltration].
Li ZJ; Chen ZX; Cen JN; Lu J; He J
Ai Zheng; 2006 Oct; 25(10):1307-10. PubMed ID: 17059783
[TBL] [Abstract][Full Text] [Related]
10. [Establishment and Identification of Mouse Model of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia].
Wang X; Qi N; Ma S; Song XG; Yan ZL; Wu QY; Wang L; Chen C; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1324-1328. PubMed ID: 27784350
[TBL] [Abstract][Full Text] [Related]
11. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J
J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201
[TBL] [Abstract][Full Text] [Related]
12. Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML).
Liu F; Wang B; Wang Q; Qi Z; Chen C; Kong LL; Chen JY; Liu X; Wang A; Hu C; Wang W; Wang H; Wu F; Ruan Y; Qi S; Liu J; Zou F; Hu Z; Wang W; Wang L; Zhang S; Yun CH; Zhai Z; Liu J; Liu Q
Oncotarget; 2016 Jul; 7(29):45562-45574. PubMed ID: 27322145
[TBL] [Abstract][Full Text] [Related]
13. [Effects of ST1571 on the development of dendritic cells derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia].
Zheng SE; Jin J; Tong XM; Qian WB; Xue YQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):920-3. PubMed ID: 17533744
[TBL] [Abstract][Full Text] [Related]
14. Chronic Myeloid Leukemia (CML) Mouse Model in Translational Research.
Peng C; Li S
Methods Mol Biol; 2016; 1438():225-43. PubMed ID: 27150093
[TBL] [Abstract][Full Text] [Related]
15. [Detection of phosphotyrosine in chronic myeloid leukemia cells with PY20 antibody and its clinical applications].
Tian J; Cheng H; Xu KL; Pan XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1056-60. PubMed ID: 19698259
[TBL] [Abstract][Full Text] [Related]
16. [Detection of phosphotyrosine in bcr-abl-positive cells with PY20 antibody and its clinical applications].
Zhu HH; Liu YR; Qin YZ; Chang Y; Li JL; Ruan GR; Jiang B; Chen SS; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):441-4. PubMed ID: 17147244
[TBL] [Abstract][Full Text] [Related]
17. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
[TBL] [Abstract][Full Text] [Related]
18. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW; Ren R
Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
[TBL] [Abstract][Full Text] [Related]
19. [Gene of DNA-dependent protein kinase catalylic subunit in chronic myeloid leukemia].
Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):248-52. PubMed ID: 17493325
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of human LIM-HOX gene hLH-2 in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
Wu HK; Minden MD
Biochem Biophys Res Commun; 1997 May; 234(3):742-7. PubMed ID: 9175786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
